儿童骨与软组织疾病3-T磁共振成像中半剂量与全剂量大环状钆对比剂的比较
该前瞻性研究纳入45例骨与软组织疾病患儿,在3-T MRI下先后给予两次半剂量钆特酸葡胺(0.05 mmol/kg),分别于首次和第二次半剂量后采集增强T1加权图像。定量分析显示半剂量与全剂量的信噪比和对比噪声比无显著差异,定性分析两组图像质量均优(Cohen κ=0.8),提示半剂量方案在不损失图像质量的前提下可行。
要点
- 儿童骨与软组织3-T MRI中,半剂量钆特酸葡胺(0.05 mmol/kg)与全剂量图像质量相当。
- 半剂量与全剂量的信噪比和对比噪声比无显著差异。
- 三位放射科医师盲法评价两组图像质量均优,观察者间一致性Cohen κ=0.8。
核心结论
- 在儿童骨与软组织3-T MRI中,将钆特酸葡胺标准剂量减半而不损失图像质量是可行的。
研究设计与样本
- 前瞻性研究,纳入45例骨与软组织疾病患儿(年龄范围2.7个月至17.5岁,中位年龄8.7岁,共49个解剖节段),在3-T MRI下先后给予两次半剂量钆特酸葡胺(0.05 mmol/kg),分别于首次和第二次半剂量后采集增强T1加权图像。
关键影像表现/征象
- 半剂量与全剂量增强T1加权图像的信噪比和对比噪声比无显著差异。
- 定性分析显示两组增强后图像质量均优,三位放射科医师盲法评价的观察者间一致性Cohen κ=0.8。
诊断标准与关键数值
- 半剂量方案为钆特酸葡胺0.05 mmol/kg,分两次连续给药,每次半剂量后采集增强T1加权图像。
- 定量比较指标为信噪比和对比噪声比,半剂量与全剂量组间无显著差异。
临床应用与阅片要点
- 在儿童骨与软组织3-T MRI增强检查中,可考虑将钆特酸葡胺标准剂量减半(0.05 mmol/kg)以降低钆暴露。
- 半剂量方案需分两次给药并分别采集图像,实际应用中需注意两次给药和采集的流程安排。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Given the recent concerns about gadolinium-based contrast agent safety, dose reduction strategies are being investigated.
OBJECTIVE: To compare half-dose and standard full-dose gadoterate meglumine at 3-tesla (T) MRI in paediatric bone and soft-tissue diseases.
MATERIALS AND METHODS: We prospectively enrolled 45 children (age range 2.7 months to 17.5 years, median age 8.7 years, 49 total anatomical segments) with bone and soft-tissue diseases (neoplastic, inflammatory/infectious, ischaemic and vascular) imaged at 3-T MRI. Two consecutive half-doses of gadoterate meglumine (0.05 mmol/kg body weight) were administered. Two sets of post-contrast T1-weighted images were obtained, one after the first half dose and the other after the second half dose. For qualitative analysis, three radiologists, masked to the gadolinium dose, compared the diagnostic quality of the images. For quantitative analysis, we compared signal-to-noise ratio and contrast-to-noise ratio at half and full doses.
RESULTS: Signal-to-noise ratio and contrast-to-noise ratio did not vary significantly between the two groups. Qualitative analysis yielded excellent image quality in both post-contrast image datasets (Cohen κ=0.8).
CONCLUSION: In paediatric bone and soft-tissue 3-T MRI, it is feasible to halve the standard dose of gadoterate meglumine without losing image quality.
引用
- Colafati GS, Rossi E, Carducci C, et al. Half-dose versus full-dose macrocyclic gadolinium at 3-T magnetic resonance imaging in paediatric bone and soft-tissue disease. Pediatr Radiol. 2018. PMID: 30046901. doi:10.1007/s00247-018-4204-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。